Lisa Glatch - 24 May 2023 Form 4 Insider Report for Evoqua Water Technologies Corp.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 24 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2023, 16:45:13 UTC
Prior SEC filing: 08 Mar 2023
Next SEC filing: 16 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ John DiMascio, Attorney-in-Fact for Lisa Glatch

Key filing fact

Lisa Glatch filed Form 4 for Evoqua Water Technologies Corp. on 26 May 2023.

Key facts

This page summarizes Lisa Glatch's Form 4 filing for Evoqua Water Technologies Corp..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2023, 16:45.

Change

Previous filing in this sequence was filed on 08 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AQUA transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -12,427
Change %: -100%
Price
Shares after: 0
Date: 24 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Lisa Glatch is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Disposed of pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023. Upon effectiveness of the merger on May 24, 2023, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") were converted into RSUs for Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.